Esperion Therapeutics, Inc. ESPR
3.18 USD 0.00 (+0.00%)
At closeJul 13, 2026, 4:00 PM EDT
3.15 -0.03 -0.94%
After hours · Jul 13, 4:00 PM ET
3.18 Day range 3.18
52-week range unavailable
- YTD
- -14.05%
- 1 year
- +211.76%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 403.13M | 332.31M | 116.33M | 75.47M | 78.45M | |
| 273.91M | 263.71M | 73.07M | 48.51M | 64.23M | |
| 60.27M | 54.40M | -155.56M | -179.50M | -226.73M | |
| -22.68M | -51.74M | -209.25M | -233.66M | -269.11M | |
| -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 167.85M | 144.76M | 82.25M | 124.78M | 258.89M | |
| 465.89M | 343.82M | 205.80M | 247.94M | 381.59M | |
| 767.85M | 732.54M | 660.79M | 571.72M | 578.53M | |
| 548.00M | 591.21M | 540.95M | 504.55M | 517.24M | |
| -301.96M | -388.72M | -454.99M | -323.78M | -196.94M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -13.09M | -23.65M | -135.49M | -174.83M | -263.81M | |
| 36.18M | 86.48M | 50.46M | 32.61M | 268.22M | |
| 23.09M | 62.51M | -42.53M | -134.12M | -46.07M |